ATAD2 and colorectal carcinoma: ATAD2 amplifies the transcription of the oncogenic ubiquitin E3 ligase TRIM25 and establishes a positive feedback circuit (ATAD2-E2Fs-TRIM25) that promotes CRC progression and therapy resistance [55].